Published in Am J Pathol on June 01, 1999
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med (2003) 12.17
Immune surveillance of tumors. J Clin Invest (2007) 5.04
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov (2014) 3.32
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science (2017) 2.69
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun (2007) 2.44
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res (2014) 2.03
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron (2010) 1.96
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol (2001) 1.95
Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer (2004) 1.80
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80
The cancer antigenome. EMBO J (2012) 1.78
Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol (2010) 1.73
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer (2013) 1.67
DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer (2010) 1.55
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) (2011) 1.50
Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Virchows Arch (2006) 1.49
Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer (2004) 1.42
A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol (2010) 1.41
Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg (2006) 1.31
Signaling defects in anti-tumor T cells. Immunol Rev (2008) 1.28
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist (2010) 1.26
Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol (2006) 1.24
Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol (2009) 1.23
High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer (2008) 1.20
Biomarkers in precision therapy in colorectal cancer. Gastroenterol Rep (Oxf) (2013) 1.15
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients. Clin Dev Immunol (2010) 1.12
Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol (2007) 1.04
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer (2007) 1.04
SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology. Nucleic Acids Res (2009) 1.02
Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Virchows Arch (2005) 1.02
Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene. J Clin Immunol (2003) 1.02
The immunogenicity of colorectal cancers with high-degree microsatellite instability. World J Surg Oncol (2005) 1.01
High lymph node yield is related to microsatellite instability in colon cancer. Ann Surg Oncol (2011) 1.00
Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. Br J Cancer (2002) 1.00
Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer. Fam Cancer (2009) 0.98
Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients. Cancer (2010) 0.98
Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome. Fam Cancer (2010) 0.98
Characterization of an adaptive immune response in microsatellite-instable colorectal cancer. Oncoimmunology (2014) 0.98
Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. Fam Cancer (2011) 0.97
Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer. PLoS One (2010) 0.95
Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer (2009) 0.94
Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer. PLoS One (2015) 0.92
Cell surface markers in colorectal cancer prognosis. Int J Mol Sci (2010) 0.90
Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer (2015) 0.90
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy. Oncotarget (2014) 0.90
Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer. Am J Surg Pathol (2008) 0.89
Colorectal cancer: molecular mutations and polymorphisms. Front Oncol (2013) 0.89
Clinical significance of microsatellite instability in colorectal cancer. Langenbecks Arch Surg (2013) 0.87
Towards a vaccine to prevent cancer in Lynch syndrome patients. Fam Cancer (2013) 0.86
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Int J Cancer (2010) 0.86
Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO). J Biomed Biotechnol (2010) 0.86
Opportunities for immunotherapy in microsatellite instable colorectal cancer. Cancer Immunol Immunother (2016) 0.86
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer. J Natl Cancer Inst (2016) 0.85
High-resolution analysis of HLA class I alterations in colorectal cancer. BMC Cancer (2006) 0.84
Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor? Dis Colon Rectum (2015) 0.83
Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms. Clin Dev Immunol (2011) 0.83
Immune checkpoints and immunotherapy for colorectal cancer. Gastroenterol Rep (Oxf) (2015) 0.83
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol (2016) 0.82
BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability. Int J Colorectal Dis (2004) 0.82
Regulatory T lymphocytes are associated with less aggressive histologic features in microsatellite-unstable colorectal cancers. PLoS One (2013) 0.80
Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine. Gynecol Oncol (2016) 0.79
Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance. Oncotarget (2015) 0.79
Lynch syndrome: clinical, pathological, and genetic insights. Langenbecks Arch Surg (2012) 0.78
[Pathogenesis of microsatellite-unstable colorectal cancer. Evaluation of new diagnostic and therapeutic options]. Pathologe (2013) 0.78
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. Oncologist (2016) 0.78
Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray. Int J Colorectal Dis (2014) 0.78
Intestinal lymphatic vasculature: structure, mechanisms and functions. Nat Rev Gastroenterol Hepatol (2017) 0.78
Molecular profiling in the treatment of colorectal cancer: focus on regorafenib. Onco Targets Ther (2015) 0.76
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal? Oncotarget (2015) 0.76
Semiallogenic fusions of MSI(+) tumor cells and activated B cells induce MSI-specific T cell responses. BMC Cancer (2011) 0.75
The significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patients. Ann Transl Med (2016) 0.75
TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells. Cell Commun Signal (2017) 0.75
Colorectal clinical trials: what is on the horizon? Future Oncol (2016) 0.75
Fas ligand expression in lynch syndrome-associated colorectal tumours. Pathol Oncol Res (2009) 0.75
CD14 and IL18 gene polymorphisms associated with colorectal cancer subsite risks among atomic bomb survivors. Hum Genome Var (2015) 0.75
Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer. Oncotarget (2016) 0.75
The Clinical Impact of Tumour-infiltrating Lymphocytes in Colorectal Cancer Differs by Anatomical Subsite: A Cohort Study. Int J Cancer (2017) 0.75
The association between microsatellite instability and lymph node count in colorectal cancer. Virchows Arch (2017) 0.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature (1993) 10.95
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res (1995) 5.26
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res (1997) 4.61
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Morphology of sporadic colorectal cancer with DNA replication errors. Gut (1998) 3.11
Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol (1996) 2.96
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer (1998) 2.91
Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology (1996) 2.60
Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45
Perforin: structure and function. Immunol Today (1995) 2.42
The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev (1992) 2.30
A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol (1990) 2.24
From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol (1994) 2.09
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet (1994) 2.08
Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (1990) 2.00
Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol (1990) 1.83
Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today (1995) 1.76
Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73
Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med (1989) 1.60
Natural history of hereditary cancer of the breast and colon. Cancer (1982) 1.53
Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. Proc Natl Acad Sci U S A (1994) 1.29
An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32. Hum Mol Genet (1992) 1.25
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer (1997) 1.20
Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. Cancer Res (1996) 1.20
Proliferation and apoptosis in proliferative lesions of the colon and rectum. Virchows Arch (1997) 1.17
Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol (1995) 1.08
A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol (1994) 1.07
Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol (1996) 1.03
A PCR-based linkage map of human chromosome 1. Genomics (1993) 1.03
An update on Lynch syndrome. Curr Opin Oncol (1998) 1.02
Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis. Br J Cancer (1997) 0.99
Intraepithelial lymphocytes in normal human intestine do not express proteins associated with cytolytic function. Am J Pathol (1997) 0.98
Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Cancer Res (1995) 0.98
Significance of spontaneous apoptosis during colorectal tumorigenesis. J Surg Oncol (1996) 0.98
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer (1998) 0.95
DNA alterations in cells from hereditary non-polyposis colorectal cancer patients. Oncogene (1994) 0.92
Hereditary nonpolyposis colorectal cancer (Lynch syndrome II). Diploid malignancies with prolonged survival. Cancer (1992) 0.90
Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21. Blood (1997) 0.86
Prognosis in familial non-polyposis colorectal cancer. Gut (1991) 0.80
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet (1993) 11.38
The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell (1993) 6.25
Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol (2007) 3.26
Twist is a potential oncogene that inhibits apoptosis. Genes Dev (1999) 3.14
Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81
Optical coherence tomography in pediatric patients: a feasible technique for diagnosing celiac disease in children with villous atrophy. Dig Liver Dis (2009) 2.69
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
Crystal structure of the repetitive segments of spectrin. Science (1993) 2.61
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
Reconstitution of simian virus 40 DNA replication with purified proteins. Proc Natl Acad Sci U S A (1990) 2.32
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol (2001) 2.13
Overexpression of folate binding protein in ovarian cancers. Int J Cancer (1997) 2.13
Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer. Surg Endosc (2007) 2.12
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol (2008) 1.99
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98
Predictors of delayed gastric emptying in diabetes. Diabetes Care (2001) 1.98
Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol (2001) 1.97
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res (1993) 1.88
Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology (1994) 1.88
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut (2005) 1.84
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol (2002) 1.74
On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. Proc Natl Acad Sci U S A (1986) 1.72
Biologically active metal-independent superoxide dismutase mimics. Biochemistry (1990) 1.72
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol (2006) 1.71
Factors affecting in-hospital heat-related mortality: a multi-city case-crossover analysis. J Epidemiol Community Health (2008) 1.70
Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol (2003) 1.69
Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64
Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut (1998) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59
Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem (1996) 1.59
Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol (1994) 1.56
Petrous bone cholesteatoma. Skull Base Surg (1993) 1.55
The impact of the summer 2003 heat waves on mortality in four Italian cities. Euro Surveill (2005) 1.55
Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A (1992) 1.54
Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys (1991) 1.53
Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit. Crit Care Med (1999) 1.50
Systematic review: green tea and gastrointestinal cancer risk. Aliment Pharmacol Ther (2004) 1.49
The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci (2005) 1.48
p53 Protein expression in nevi and melanomas. Arch Dermatol (1993) 1.44
Left atrial thrombus and spontaneous echo-contrast in nonanticoagulated mitral stenosis. A transesophageal echocardiographic study. Chest (1993) 1.43
Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene (2008) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
[Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases]. J Fr Ophtalmol (2013) 1.40
Antithrombotic drugs in secondary stroke prevention among a community dwelling older population. J Neurol Neurosurg Psychiatry (2003) 1.40
Facial nerve neuromas: diagnosis and management. Am J Otol (1995) 1.40
Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing's disease. J Endocrinol Invest (2004) 1.39
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile? Dig Liver Dis (2000) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res (1995) 1.39
Fibroepithelial tumor of the breast with digital fibroma-like inclusions in the stromal component. Case report with immunocytochemical and ultrastructural analysis. Am J Surg Pathol (1994) 1.38
Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Ital J Gastroenterol Hepatol (1997) 1.38
Leukocyte alkaline phosphatase (LAP). A useful marker of zinc status in beta-thalassemic patients. Am J Pediatr Hematol Oncol (1987) 1.38
Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem (1997) 1.37
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer (1998) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Breast cancer genome-wide association studies: there is strength in numbers. Oncogene (2011) 1.34
Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol (2006) 1.33
Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem (1996) 1.33
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet (2004) 1.33
Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia (2002) 1.33
Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology (1992) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene (1992) 1.30
Myringoplasty in children: factors influencing surgical outcome. Otolaryngol Head Neck Surg (1998) 1.29
Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res (1993) 1.29
Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol (2002) 1.29
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Ann Oncol (2012) 1.28
Large-scale spatial distribution of virioplankton in the Adriatic Sea: testing the trophic state control hypothesis. Appl Environ Microbiol (2003) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res (1986) 1.27
A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem (1988) 1.26
Pain management in frail, community-living elderly patients. Arch Intern Med (2001) 1.26
In vivo imaging of a stable paramagnetic probe by pulsed-radiofrequency electron paramagnetic resonance spectroscopy. Magn Reson Med (1997) 1.26
Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer (2001) 1.26
Photodynamic therapy. J Clin Oncol (1988) 1.25
Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res (1997) 1.25
Discriminative and predictive power of an informant report in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.25
Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis (1994) 1.24
Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. Am J Pathol (1998) 1.24
Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care (1998) 1.24